Skip to main content
. 2022 Jan 19;9(3):ofac029. doi: 10.1093/ofid/ofac029

Figure 3.

Figure 3.

Adjusted incidence of cancer, by integrase inhibitor (INSTI) exposure compared to no exposure, stratified by antiretroviral treatment (ART)-experience at baseline. Incidence rate ratio (IRR) calculated from a negative binomial regression model, adjusted for the same confounders as the main analysis, and including an interaction term between INSTI exposure and ART-experience at baseline. ADC, acquired immune deficiency syndrome (AIDS)-defining cancers; NADC, non-AIDS-defining cancers; VL, viral load.